These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 17982156)

  • 1. Plasma androgen concentrations and risk of incident ovarian cancer.
    Tworoger SS; Lee IM; Buring JE; Hankinson SE
    Am J Epidemiol; 2008 Jan; 167(2):211-8. PubMed ID: 17982156
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insulin-like growth factors and ovarian cancer risk: a nested case-control study in three cohorts.
    Tworoger SS; Lee IM; Buring JE; Pollak MN; Hankinson SE
    Cancer Epidemiol Biomarkers Prev; 2007 Aug; 16(8):1691-5. PubMed ID: 17684148
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum sex steroids in premenopausal women and breast cancer risk within the European Prospective Investigation into Cancer and Nutrition (EPIC).
    Kaaks R; Berrino F; Key T; Rinaldi S; Dossus L; Biessy C; Secreto G; Amiano P; Bingham S; Boeing H; Bueno de Mesquita HB; Chang-Claude J; Clavel-Chapelon F; Fournier A; van Gils CH; Gonzalez CA; Gurrea AB; Critselis E; Khaw KT; Krogh V; Lahmann PH; Nagel G; Olsen A; Onland-Moret NC; Overvad K; Palli D; Panico S; Peeters P; Quirós JR; Roddam A; Thiebaut A; Tjønneland A; Chirlaque MD; Trichopoulou A; Trichopoulos D; Tumino R; Vineis P; Norat T; Ferrari P; Slimani N; Riboli E
    J Natl Cancer Inst; 2005 May; 97(10):755-65. PubMed ID: 15900045
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endogenous steroid hormone concentrations and risk of breast cancer among premenopausal women.
    Eliassen AH; Missmer SA; Tworoger SS; Spiegelman D; Barbieri RL; Dowsett M; Hankinson SE
    J Natl Cancer Inst; 2006 Oct; 98(19):1406-15. PubMed ID: 17018787
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The association of plasma DHEA and DHEA sulfate with breast cancer risk in predominantly premenopausal women.
    Tworoger SS; Missmer SA; Eliassen AH; Spiegelman D; Folkerd E; Dowsett M; Barbieri RL; Hankinson SE
    Cancer Epidemiol Biomarkers Prev; 2006 May; 15(5):967-71. PubMed ID: 16702378
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Postmenopausal serum androgens, oestrogens and breast cancer risk: the European prospective investigation into cancer and nutrition.
    Kaaks R; Rinaldi S; Key TJ; Berrino F; Peeters PH; Biessy C; Dossus L; Lukanova A; Bingham S; Khaw KT; Allen NE; Bueno-de-Mesquita HB; van Gils CH; Grobbee D; Boeing H; Lahmann PH; Nagel G; Chang-Claude J; Clavel-Chapelon F; Fournier A; Thiébaut A; González CA; Quirós JR; Tormo MJ; Ardanaz E; Amiano P; Krogh V; Palli D; Panico S; Tumino R; Vineis P; Trichopoulou A; Kalapothaki V; Trichopoulos D; Ferrari P; Norat T; Saracci R; Riboli E
    Endocr Relat Cancer; 2005 Dec; 12(4):1071-82. PubMed ID: 16322344
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A prospective study of plasma prolactin concentrations and risk of premenopausal and postmenopausal breast cancer.
    Tworoger SS; Eliassen AH; Sluss P; Hankinson SE
    J Clin Oncol; 2007 Apr; 25(12):1482-8. PubMed ID: 17372279
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma adrenal androgens and risk of breast cancer in premenopausal women.
    Page JH; Colditz GA; Rifai N; Barbieri RL; Willett WC; Hankinson SE
    Cancer Epidemiol Biomarkers Prev; 2004 Jun; 13(6):1032-6. PubMed ID: 15184260
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Androgens and prostate cancer risk: a prospective study.
    Wirén S; Stocks T; Rinaldi S; Hallmans G; Bergh A; Stenman UH; Kaaks R; Stattin P
    Prostate; 2007 Aug; 67(11):1230-7. PubMed ID: 17562541
    [TBL] [Abstract][Full Text] [Related]  

  • 10. C-reactive protein concentrations and subsequent ovarian cancer risk.
    McSorley MA; Alberg AJ; Allen DS; Allen NE; Brinton LA; Dorgan JF; Pollak M; Tao Y; Helzlsouer KJ
    Obstet Gynecol; 2007 Apr; 109(4):933-41. PubMed ID: 17400857
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Caffeine, alcohol, smoking, and the risk of incident epithelial ovarian cancer.
    Tworoger SS; Gertig DM; Gates MA; Hecht JL; Hankinson SE
    Cancer; 2008 Mar; 112(5):1169-77. PubMed ID: 18213613
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Androgens and breast cancer in premenopausal women.
    Secreto G; Toniolo P; Pisani P; Recchione C; Cavalleri A; Fariselli G; Totis A; Di Pietro S; Berrino F
    Cancer Res; 1989 Jan; 49(2):471-6. PubMed ID: 2521298
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intake of folate and related nutrients in relation to risk of epithelial ovarian cancer.
    Tworoger SS; Hecht JL; Giovannucci E; Hankinson SE
    Am J Epidemiol; 2006 Jun; 163(12):1101-11. PubMed ID: 16554344
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of oral contraceptive use, other contraceptive methods, and infertility with ovarian cancer risk.
    Tworoger SS; Fairfield KM; Colditz GA; Rosner BA; Hankinson SE
    Am J Epidemiol; 2007 Oct; 166(8):894-901. PubMed ID: 17656616
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Testosterone/androstenedione ratio in the evaluation of women with ovarian androgen excess.
    Wiebe RH; Morris CV
    Obstet Gynecol; 1983 Mar; 61(3):279-84. PubMed ID: 6296743
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Associations between reproductive and menstrual factors and postmenopausal androgen concentrations.
    Chubak J; Tworoger SS; Yasui Y; Ulrich CM; Stanczyk FZ; McTiernan A
    J Womens Health (Larchmt); 2005 Oct; 14(8):704-12. PubMed ID: 16232102
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum follicle-stimulating hormone and risk of epithelial ovarian cancer in postmenopausal women.
    Arslan AA; Zeleniuch-Jacquotte A; Lundin E; Micheli A; Lukanova A; Afanasyeva Y; Lenner P; Krogh V; Muti P; Rinaldi S; Kaaks R; Berrino F; Hallmans G; Toniolo P
    Cancer Epidemiol Biomarkers Prev; 2003 Dec; 12(12):1531-5. PubMed ID: 14693749
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recreational physical activity and sedentary behavior in relation to ovarian cancer risk in a large cohort of US women.
    Patel AV; Rodriguez C; Pavluck AL; Thun MJ; Calle EE
    Am J Epidemiol; 2006 Apr; 163(8):709-16. PubMed ID: 16495470
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D and risk of incident ovarian cancer.
    Tworoger SS; Lee IM; Buring JE; Rosner B; Hollis BW; Hankinson SE
    Cancer Epidemiol Biomarkers Prev; 2007 Apr; 16(4):783-8. PubMed ID: 17416771
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum dehydroepiandrosterone and dehydroepiandrosterone sulfate and the subsequent risk of developing colon cancer.
    Alberg AJ; Gordon GB; Hoffman SC; Comstock GW; Helzlsouer KJ
    Cancer Epidemiol Biomarkers Prev; 2000 May; 9(5):517-21. PubMed ID: 10815698
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.